Author ORCID Identifier
https://orcid.org/0000-0002-6326-1529
Date of Graduation
8-2019
Document Type
Thesis (MS)
Program Affiliation
Biomedical Sciences
Degree Name
Masters of Science (MS)
Advisor/Committee Chair
Radbod Darabi, MD, PhD
Committee Member
Brian Davis, PhD
Committee Member
Hamed Jafar-Nejad, MD
Committee Member
Vihang Narkar, PhD
Committee Member
Sarah (Xuelian) Huang MBBS, PhD
Abstract
Recently, a novel class of muscular dystrophy has been discovered in a family due to autosomal recessive missense mutation in POGLUT1. Mutation of this enzyme leads to decreased O-glucosyltransferase activity and impaired Notch signaling, the pathways important for skeletal muscle stem cell (satellite cells) quiescence and activation. We hypothesize that reduced POGLUT1 activity and impaired Notch signaling is causative of this limb girdle muscular dystrophy through dysfunction of muscle stem cells and myogenic progenitors.
To test this, we have used iPSCs for disease modeling and rescue experiments. Using a CRISPR based gene targeting method, we aimed to correct the point mutation and restore POGLUT1 function, thus restoring Notch signaling activity. Following correction, iPSC-derived gene corrected myogenic cells were differentiated and compared to healthy control and patient cell line (isogenic control). Compared to patient cells, gene-corrected cells demonstrated superior ability to proliferate and improved myogenic potential as compared to patient uncorrected cells. In addition, Notch signaling pathway activity was improved in the corrected cells as a result of the POGULT1 gene correction. These results support our hypothesis that POGULT1 modulates Notch signaling in myogenic cells and its involvement may be responsible for the development of this type of LGMD.
Keywords
iPSC, Gene Editing, LGMD, Disease Model, Differentiation, Skeletal Muscle
Included in
Biotechnology Commons, Cell Biology Commons, Laboratory and Basic Science Research Commons, Molecular Biology Commons